Cambodia has made history by becoming the first country in the Asia-Pacific region to offer Cabotegravir, a long-acting injectable medication that helps prevent HIV!
What is Cabotegravir (CAB-LA)?
It's a shot you get once every two months no daily pills needed, and is especially helpful for groups like:
- Female sex workers
- Transgender individuals
- Men who have sex with men
- People who use intravenous drugs
With up to 95% effectiveness, CAB-LA offers strong protection and more privacy than traditional daily pills.
Why it matters
This new method gives people more choices and control over their health.
Cambodia's Ministry of Health says its part of a broader strategy to fight HIV with multiple prevention options. The launch event was attended by key health leaders and international partners.
More coming soon
Next up is the Dapivirine Vaginal Ring (DVR) another long-acting HIV prevention tool designed specifically for women.
Efficacy?
- Around 76,000 people in Cambodia were living with HIV in 2024
- About 1,200 new infections and 1,000 AIDS-related deaths
- HIV rate among the general population: just 0.5%
- Most new cases are among young men (1524), transgender people, and entertainment workers
92% of people with HIV know their status, and nearly all of them are receiving treatment. 98% of those on treatment have suppressed the virus. Since 2010, new HIV infections in Cambodia have dropped by 45%.
